The first plenary meeting of the new term of the Chinese Medicine Development Fund
The appointments of new Advisory Committee on Chinese Medicine Development Fund took effect from March 1, 2025, for a term of two years. Our Managing Director, Sr Serena Lau was appointed as the Chairperson of the new Advisory Committee. The committee,which is appointed by the Secretary for Health, focuses on providing advice on coverage,implementation plans, publicity and promotion and application approval of the various funding schemes.
The committee held its first plenary meeting on March 27, the new chairperson, Sr Lau stated that the committee will continue to align with the government's policy guidelines and development direction to enable the Chinese Medicine Development Fund to play a more strategic role; It will provide support in areas such as talent nurturing,quality enhancement, market development, public education as well as scientific research and innovation, in order to enhance the overall standard of the CM sector to promote the high-quality development of CM in Hong Kong on all aspects.
